These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21540059)

  • 1. Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.
    Haghdoost-Yazdi H; Faraji A; Fraidouni N; Movahedi M; Hadibeygi E; Vaezi F
    Behav Brain Res; 2011 Sep; 223(1):70-4. PubMed ID: 21540059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
    Haghdoost-Yazdi H; Piri H; Faraji A; Fraidouni N; Dargahi T; Mahmudi M; Alipour Heidari M
    Neurol Res; 2016 Apr; 38(4):294-300. PubMed ID: 27098232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
    Haghdoost-Yazdi H; Piri H; Najafipour R; Faraji A; Fraidouni N; Dargahi T; Alipour Heidari M
    Neurosciences (Riyadh); 2017 Jan; 22(1):44-50. PubMed ID: 28064330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ
    Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R; Mohapel P; Brundin P; Paul G
    Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK; Lim HH; Song YK; Lee HH; Lim S; Han SM; Kim CJ
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):133-8. PubMed ID: 15893426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S; Huang H; Bi J; Yao Y; Wen T
    Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty.
    van Oosten RV; Cools AR
    Exp Neurol; 2002 Feb; 173(2):245-55. PubMed ID: 11822888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
    Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
    Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.
    Truong L; Allbutt H; Kassiou M; Henderson JM
    Behav Brain Res; 2006 Apr; 169(1):1-9. PubMed ID: 16413939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
    Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
    Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.
    Baluchnejadmojarad T; Roghani M; Nadoushan MR; Bagheri M
    Phytother Res; 2009 Jan; 23(1):132-5. PubMed ID: 18693302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
    Fleming SM; Delville Y; Schallert T
    Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.